Heart Disease News and Research

Latest Heart Disease News and Research

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Statins, a class of drugs used to lower cholesterol, are among the best selling drugs in North America and around the world. However, statin myopathy, which results in muscle pain and weakness, is a common side effect affecting up to 10 percent of statin users. A recent study led by Dr. Richard Kim of the Lawson Health Research Institute, in collaboration with Dr. Robert Hegele of Robarts Research Institute, and researchers from Vanderbilt University, found that commonly occurring genetic variations in a person's genes could put them at risk for statin-associated muscle injury.

7 Aug 2013

Health benefits of sufficient sleep: an interview with Dr Monique Verschuren, National Institute for Public Health and the Environment, the Netherlands

We used 6 hours or less per 24 hours as the definition of insufficient sleep, with 7 hours or more as sufficient sleep. In general, this is considered the amount of sleep that is sufficient for adults, although there can be differences between persons with respect to the amount of sleep needed.

6 Aug 2013

Studies show that hTEE technology changes patient management in critical care

ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.

6 Aug 2013

Meridian Health earns Chest Pain Center Accreditation

Meridian Health, a leading New Jersey health care system, has recently earned the highest designated Chest Pain Center Accreditation by the Society of Cardiovascular Patient Care, a global not-for-profit organization committed to leading the fight to eliminate heart disease as the number one cause of death worldwide.

6 Aug 2013

Isis Pharmaceuticals announces results of ISIS-CRPRx Phase 2 study in RA patients

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that patients treated with ISIS-CRPRx achieved rapid, dose-dependent mean reductions of up to 67 percent in C-reactive protein (CRP) in a Phase 2 study in patients with rheumatoid arthritis (RA).

6 Aug 2013

Study observes that long-term use of antihypertensive drugs associated with breast cancer risk

Older women who take certain types of medication to combat high blood pressure may be putting themselves at greater risk for developing breast cancer, according to a new study by a team of Fred Hutchinson Cancer Research Center scientists led by Christopher Li, M.D., Ph.D.

6 Aug 2013

NIH-funded study of aquaporin proteins could hold clues to cataract

Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye. The work, funded in part by the National Institutes of Health, could lead to new insights and drugs for treating cataract and a variety of other health conditions.

6 Aug 2013

Virginia Tech addiction expert receives $3.2 million grant to help smokers quit cigarettes

Warren Bickel, an internationally recognized addiction expert at the Virginia Tech Carilion Research Institute, recently received a $3.2-million grant from the National Institute on Drug Abuse for research on improving self-control in smokers seeking to quit cigarettes. The grant will provide Bickel's team with $573,000 to $716,000 a year over five years to develop innovative new ways to enhance the smokers' ability to abstain from acting on their nicotine cravings.

6 Aug 2013

People who walk to work are less likely to have diabetes and high blood pressure

People who walk to work are around 40 per cent less likely to have diabetes as those who drive, according to a new study.

6 Aug 2013

High-calorie breakfast protects against diabetes, hypertension and cardiovascular problems

Whether you hope to lose weight or just stay healthy, what you eat is a crucial factor. The right nutrients can not only trim your waistline, but also provide energy, improve your mood, and stave off disease. Now a Tel Aviv University researcher has found that it's not just what you eat - but when.

6 Aug 2013

NPS MedicineWise programs improve prescribing, cardiovascular management in primary care

NPS MedicineWise programs targeting quality use of medicines in cardiovascular management have improved prescribing and cardiovascular disease management in primary care, according to a study published in the Medical Journal of Australia today.

5 Aug 2013

MEDNAX acquires Holston Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of Holston Anesthesia Associates, P.C., a physician group practice based in Kingsport, Tenn. The practice will become part of MEDNAX's American Anesthesiology division and is the third Tennessee-based anesthesiology practice to join this division.

5 Aug 2013

Prospective health of the Hispanic/Latino population in the US: an interview with Dr. Martha Daviglus, University of Illinois at Chicago

Heart disease is one of the leading causes of death among Hispanic/ Latino adults living in the US and this population is known to have high rates of obesity and diabetes.

5 Aug 2013

Study opens door to possible treatments for variety of mitochondrial diseases

By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria-the energy factories within cells. Doctors might someday use the approach to treat a variety of mitochondrial diseases, including the degenerative eye disease Leber hereditary optic neuropathy. The research, published online today in Nature Medicine, was funded by the National Eye Institute, a part of the National Institutes of Health.

5 Aug 2013

Vanderbilt University scientists discover new approach to treating mood, anxiety disorders

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects, Vanderbilt University scientists will report next week.

5 Aug 2013

European authorisation of Aegerion Pharmaceuticals' Lojuxta brings hope for HoFH patients

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialisation of novel, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced today that the European Commission has authorised Lojuxta (lomitapide) hard capsules as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein apheresis in adult patients with homozygous familial hypercholesterolaemia.

3 Aug 2013

Research roundup: Making sense (or not) of health insurance; what a full Medicaid expansion could look like; recession and coverage

Each week, KHN reporter Alvin Tran compiles a selection of recently released health policy studies and briefs.

3 Aug 2013

Jersey Shore hospital participates in clinical study of investigational vaccine for prevention of CDI

Mark Martens, M.D., chief of Obstetrics and Gynecology at Jersey Shore University Medical Center, announces that the hospital is participating in a clinical study to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI).

3 Aug 2013

Viewpoints: Shutting down the government over health law is 'nutty' idea; GOP's Obamacare playbook for summer recess

Led by Sens. Mike Lee and Ted Cruz, the GOP insurgents are threatening to shut down the government on Oct. 1 if the stopgap funding bill contains money for Obamacare. This is nuts. The president will never sign a bill defunding the singular achievement of his presidency. Especially when he has control of the Senate. Especially when, though a narrow 51 percent majority of Americans disapproves of Obamacare, only 36 percent favors repeal. President Obama so knows he'll win any shutdown showdown that he's practically goading the Republicans into trying. ... Every fiscal showdown has redounded against the Republicans (Charles Krauthammer, 8/1).

3 Aug 2013

Clot-inhibiting drug apixaban shows added benefits in adults with non-valvular atrial fibrillation

The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation.

3 Aug 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Health benefits of sufficient sleep: an interview with Dr Monique Verschuren, National Institute for Public Health and the Environment, the Netherlands

Studies show that hTEE technology changes patient management in critical care

Meridian Health earns Chest Pain Center Accreditation

Isis Pharmaceuticals announces results of ISIS-CRPRx Phase 2 study in RA patients

Study observes that long-term use of antihypertensive drugs associated with breast cancer risk

NIH-funded study of aquaporin proteins could hold clues to cataract

Virginia Tech addiction expert receives $3.2 million grant to help smokers quit cigarettes

People who walk to work are less likely to have diabetes and high blood pressure

High-calorie breakfast protects against diabetes, hypertension and cardiovascular problems

NPS MedicineWise programs improve prescribing, cardiovascular management in primary care

MEDNAX acquires Holston Anesthesia Associates

Prospective health of the Hispanic/Latino population in the US: an interview with Dr. Martha Daviglus, University of Illinois at Chicago

Study opens door to possible treatments for variety of mitochondrial diseases

Vanderbilt University scientists discover new approach to treating mood, anxiety disorders

European authorisation of Aegerion Pharmaceuticals' Lojuxta brings hope for HoFH patients

Research roundup: Making sense (or not) of health insurance; what a full Medicaid expansion could look like; recession and coverage

Jersey Shore hospital participates in clinical study of investigational vaccine for prevention of CDI

Viewpoints: Shutting down the government over health law is 'nutty' idea; GOP's Obamacare playbook for summer recess

Clot-inhibiting drug apixaban shows added benefits in adults with non-valvular atrial fibrillation

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in